HIND 股價走勢圖
HIND 財務
Vyome Holdings Inc
$2.1
-4.54%
$-0.1
收盤價：May 07, 16:00:00 GMT-4
$2.08
-0.53%
$-0.01
盤後：May 07, 20:00:00 GMT-4
返回
Vyome Holdings Inc (HIND) 財務
關鍵數據
前收市價
$2.2
開盤價
$2.19
當日範圍
$2.08 - $2.21
52週區間
$1.75 - $46.6
交易量
6.1K
平均成交量
597.7K
股息收益率
--
每股盈餘 (TTM)
63.63
市值
$14.6M
什麼是 HIND？
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
